Paper25317186
Effect of Skimmed Milk on the Absorption and Metabolism of5-Fluorouracil (5-FU) in Animals.
Ahmad M and 5 others. Iran J Pharm Res, 2012. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Effect of Skimmed Milk on the Absorption and Metabolism of5-Fluorouracil (5-FU) in Animals. Papers, record 25317186. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25317186
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effect of Skimmed Milk on the Absorption and Metabolism of5-Fluorouracil (5-FU) in Animals.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10,499,595 | The oral fluoropyrimidines in cancer chemotherapy. | Clin Cancer Res | 1999 | https://conductscience.org/library/papers/10499595 | PubMed |
| 2 | 14,254,828 | EFFECTIVENESS AND TOXICITY OF PROLONGED INFUSIONS OF 5-FLUOROURACIL IN THE TREATMENT OF CANCER. | Am J Med Sci | 1965 | https://conductscience.org/library/papers/14254828 | PubMed |
| 3 | 4,609,602 | Clinical pharmacology of oral and intravenous 5-fluorouracil (NSC-19893). | Cancer Chemother Rep | 1974 | https://conductscience.org/library/papers/4609602 | PubMed |
| 4 | 7,388,790 | Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion. | Cancer Res | 1980 | https://conductscience.org/library/papers/7388790 | PubMed |
| 5 | 16,173,332 | Prevention of oral mucositis due to 5-fluorouracil treatment with oral cryotherapy. | J Natl Med Assoc | 2005 | https://conductscience.org/library/papers/16173332 | PubMed |
| 6 | 2,293,556 | Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion. | Cancer Res | 1990 | https://conductscience.org/library/papers/2293556 | PubMed |
| 7 | 3,049,954 | Fluorouracil: biochemistry and pharmacology. | J Clin Oncol | 1988 | https://conductscience.org/library/papers/3049954 | PubMed |
| 8 | 11,585,968 | The evolution of fluoropyrimidine therapy: from intravenous to oral. | Oncologist | 2001 | https://conductscience.org/library/papers/11585968 | PubMed |
| 9 | 3,280,741 | A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. | J Clin Oncol | 1988 | https://conductscience.org/library/papers/3280741 | PubMed |
| 10 | 465,283 | Plasma levels of 5-fluorouracil after oral and intravenous administration in cancer patients. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/465283 | PubMed |
| 11 | 11,291,832 | The oral fluorinated pyrimidines. | Invest New Drugs | 2001 | https://conductscience.org/library/papers/11291832 | PubMed |
| 12 | 11,709,571 | Fluorouracil (5FU) pharmacokinetics in 5FU prodrug formulations with a dihydropyrimidine dehydrogenase inhibitor. | J Clin Oncol | 2001 | https://conductscience.org/library/papers/11709571 | PubMed |
| 13 | 1,406,460 | Antibacterial effect of bovine milk antibody against Escherichia coli in a mouse indigenous infection model. | Med Microbiol Immunol | 1992 | https://conductscience.org/library/papers/1406460 | PubMed |
| 14 | 3,920,827 | [Prophylactic effect of enteral feeding preparations during the chemotherapy of oncology patients]. | Vopr Pitan | 1985 | https://conductscience.org/library/papers/3920827 | PubMed |
| 15 | 3,829,006 | Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile. | Cancer Res | 1987 | https://conductscience.org/library/papers/3829006 | PubMed |
| 16 | 678,346 | Fluorouracil therapy in patients with carcinoma of the large bowel: a pharmacokinetic comparison of various rates and routes of administration. | Clin Pharmacokinet | 1978 | https://conductscience.org/library/papers/678346 | PubMed |
| 17 | 2,926,468 | A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study. | J Clin Oncol | 1989 | https://conductscience.org/library/papers/2926468 | PubMed |
| 18 | 1,512,248 | Purification and characterization of dihydropyrimidine dehydrogenase from human liver. | J Biol Chem | 1992 | https://conductscience.org/library/papers/1512248 | PubMed |
| 19 | 12,378,555 | Simultaneous HPLC determination of 5-fluorouracil and its metabolites in plasma of cancer patients. | Biomed Chromatogr | 2002 | https://conductscience.org/library/papers/12378555 | PubMed |
| 20 | 8,636,939 | Experimental endogenous septicaemia caused by Klebsiella pneumoniae and Escherichia coli in mice. | J Med Microbiol | 1996 | https://conductscience.org/library/papers/8636939 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| DPYD | 1,806 | PubTator's text mining | https://conductscience.org/library/genes/1806 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25317186
GET https://conductscience.org/api/papers/v1/25317186/references?page=2